06/09/2025
3:16 PM | Celldex Therapeutics (Issuer)
PEPIN RONALD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:17 PM | Celldex Therapeutics (Issuer)
Martin Samuel Bates (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:18 PM | Celldex Therapeutics (Issuer)
Jimenez Freddy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:21 PM | Celldex Therapeutics (Issuer)
Heath-Chiozzi Margo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:22 PM | Celldex Therapeutics (Issuer)
Crowley Elizabeth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:22 PM | Cavanaugh Sarah (Reporting)
Celldex Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:05 AM | Celldex Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
7:10 AM | Celldex Therapeutics (Issuer)
Torres Denice (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/15/2025
10:48 AM | Celldex Therapeutics (Subject)
Kynam Capital Management, LP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
9:44 AM | Celldex Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
04/21/2025
7:01 AM | Celldex Therapeutics (Filer)
| Form DEF 14A | |
04/10/2025
3:05 PM | Celldex Therapeutics (Subject)
COMMODORE CAPITAL LP (Filed by)
| Form SCHEDULE 13G | |
02/27/2025
3:01 PM | Celldex Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:16 PM | Celldex Therapeutics (Subject)
Kynam Capital Management, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
8:44 AM | Celldex Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/12/2025
8:28 AM | Celldex Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
11/14/2024
6:47 PM | Celldex Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
11:18 AM | Celldex Therapeutics (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
5:12 AM | Celldex Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024
5:00 PM | Celldex Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
11/12/2024
8:55 AM | Celldex Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Celldex Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:06 PM | Celldex Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
